Research Methodology – Autoimmune Therapeutics Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Autoimmune Therapeutics Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Autoimmune Therapeutics Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Prevalence and incidence rate of autoimmune diseases globally.
- Investments in research and development of autoimmune therapeutics.
- Current and future market penetration rates of various autoimmune therapeutics.
- Revenue of key players in the autoimmune therapeutics market.
- Government spending in healthcare sector.
- Impact of new product launches on the market size.
- Price of the autoimmune treatment drugs.
- Patent expiries and introduction of generics.
- Approval and distribution of novel and existing autoimmune drugs.
Key Market Indicators
- Revenues of top pharmaceutical companies in autoimmune therapeutics market.
- Growth rate of the autoimmune therapeutics market.
- Number of patents filed and received for autoimmune therapeutics.
- Number of new product launches and their market acceptance.
- Rates of prevalence and incidence of various autoimmune disorders in different regions.
- Government funding towards autoimmune disease research and therapeutics.
Growth Trends
- Increasing prevalence of autoimmune diseases contributing to the market growth.
- Advancements in biotechnology and pharmaceutical sectors fueling the market expansion.
- Increasing investment in research and development activities for autoimmune therapeutics.
- Increasing FDA approvals for autoimmune therapeutics stimulating the market growth.
- Growing public awareness and early disease diagnosis.
- Growth in demand for personalized medicine in autoimmune diseases.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Autoimmune Therapeutics Market. Key inputs include:
Company-Level Information
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
Industry and Government Sources
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Autoimmune Therapeutics Market
Market Intelligence Sources
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
Macro & Consumer Insights
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
Expert Insights & KOL Engagements
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
Focused Discussions & Panels
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
Data Validation & Business POV
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
Forecasting is carried out using proprietary models that combine:
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights